EGFR and cancer: EGFR/RAS/ERK signaling is often aberrantly activated in cancer, resulting in cell proliferation, malignant transformation, and drug resistance.20–22 Furthermore, this pathway can directly phosphorylate numerous transcription factors, including ETS-1, c-JUN, and c-MYC.